Drug Type Small molecule drug |
Synonyms |
Target |
Action inhibitors |
Mechanism CREBBP inhibitors(cAMP-response element binding protein inhibitors), EP300 inhibitors(Histone acetyltransferase p300 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Relapsed Solid Neoplasm | Phase 1 | India | 05 Sep 2023 | |
Bladder Cancer | Phase 1 | India | - | |
Leukemia | Phase 1 | India | - | |
Lymphoma | Phase 1 | India | - | |
Non-Small Cell Lung Cancer | Phase 1 | India | - | |
Prostatic Cancer | Phase 1 | India | - |